A decade-long commitment to medically supervised care, advanced wellness therapies, and personalized health solutions ...
Five weeks after launch, Novo Nordisk’s oral Wegovy recorded 38,220 US prescriptions, boosting shares 4 percent. Studies show ...
Semaglutide is used for the treatment of adults with insufficiently controlled type 2 diabetes mellitus and chronic weight management.
Aimee Donnellan has been a correspondent for Reuters since 2017. Her patch includes the pharmaceutical industry. Off the Scales is her first book. In brisk and breezy terms, it recounts the history ...
Doctors are recommending these three peptides as possible solutions to a number of longevity issues — from cell rejuvenation to metabolic health and risk of heart disease.
A widely used diabetes and weight loss medication may do more than lower blood sugar and help people shed pounds. New ...
Gina Roberts folds up blankets on her bed in the sober home where she’s been living in Providence, R.I. on Feb. 2. She has ...
Novo Nordisk plans to sell Wegovy in vials in the U.S., expanding options as it competes with Eli Lilly in the growing weight ...
GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections ...
Once-weekly CagriSema significantly reduced HbA1c and body weight vs semaglutide in patients with type 2 diabetes in the REIMAGINE 2 trial.
The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...
Biomed Industries, Inc. Announces Two NA-931 Phase 3 Trials, Targeting Durable Weight Loss & Lean-Mass Preservation ...